Scientific Program
 
Scientific ProgramSearch Abstract
 
Session
 
Myelodysplastic syndromes I
Date: Friday, 05 June 2009
Time:17:45-19:00
Room:
 
17:45-19:00
LENALIDOMIDE ABROGATES THE CLONAL ADVANTAGE OF DEL(5Q) MDS STEM CELLS VIA ALTERATION OF NICHE INTERACTIONS 0246
Scharenberg, Christian, Jädersten, Martin, Palmquist, Joakim, Forsblom, Lalla, Jansson, Monika, Hellström-Lindberg, Eva (Stockholm, Sweden)
 
17:45-19:00
EVALUATION OF COMORBIDITY AS PROGNOSTIC VARIABLE IN 419 PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A STUDY OF THE AUSTRIAN MDS WORKING GROUP 0247
Sperr, Wolfgang Reinhard, Wimazal, Friedrich, Kundi, Michael, Baumgartner, Christian, Nösslinger, Thomas, Makrai, Anabel, Stauder, Reinhard, Krieger, Otto, Pfeilstoecker, Michael, Valent, Peter (Vienna, Austria)
 
17:45-19:00
A NOVEL RECURRENT GENETIC ABNORMALITY IN MYELODYSPLASTIC SYNDROMES (MDS): REARRANGEMENTS AND AMPLIFICATIONS OF IER3 0248
Steensma, David, Neiger, Jessemy, Porcher, Julie, Keats, Jonathan, Bergsagel, Leif, Knudson, Ryan, Santana-Davila, Rafael, Kumar, Rajiv, Ketterling, Rhett (Rochester Minnesota, United States of America)
 
17:45-19:00
NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING 0249
Nikpour, Maryam, Pellagatti, Andrea, Liu, Anquan, Karimi, Mohsen, Malcovati, Luca, Forsblom, Ann-Mari, Gogvadze, Vladimir, Wainscoat, James, Cazzola, Mario, Zhivotovsky, Boris, Grandien, Alf, Boultwood, Jacqueline, Hellström-Lindberg, Eva (Huddinge Stockholm, Sweden)
 
17:45-19:00
ABT 737 BCL-2 INHIBITOR TARGETS LEUKEMIC STEM CELLS IN MOUSE MODELS OF MYELOID (PRE)LEUKAEMIA 0250
Padua, Rose-Ann, Beurlet, Stéphanie, Saeed, Mohamed, Omidvar, Nader, Krief, Patricia, Auboeuf, Didier, Le Pogam, Carole, Reboul, Murielle, Soulié, Annie, Janin, Anne, Noguera, Maria-Elena, Merlet, Pascal, Sarda-Mentel, Laure, Fenaux, Pierre, Fontenay, Michaela, Konopleva, Marina, Andreeff, Michael, Mufti, Ghulam, Rassool, Feyruz, Mills, Ken, Tu, Andrea, Voehringer, David, Pla, Marika, Chomienne, Christine (Paris, France)
 
17:45-19:00
FISH PROBES DERIVED FROM ARRAY CGH (ACGH) REVEAL NOVEL CHROMOSOMAL LESIONS IN MDS PATIENTS WITH A NORMAL KARYOTYPE 0251
Bernasconi , Paolo, Dambruoso, Irene, Boni, Marina, Cavigliano, Paola Maria, Calatroni, Silvia, Giardini, Ilaria, Rocca, Barbara, Zappatore, Rita, Calvello, Celeste, Caresana, Marilena, Lazzarino, Mario (Pavia, Italy)
 
17:45-19:00
ALLOGENIC STEM CELL TRANSPLANT IN MDS: RESULTS OF THE SPANISH REGISTRY 0252
Lopez-Villar, Olga, Cordoba, Iris, Martino, Rodrigo, Perez-Simon, Jose Antonio, Gomez, Valle, Bernal, Teresa, Duarte, Rafael, Tormo, Mar, Xicoy, Blanca, Bargay, Joan, Salido, Eduardo, Benlloch, Luis, Sanz, Guillermo, Del Cañizo, Maria Consuelo, Registro Español de SMD, RE-SMD, Grupo Español de Transplante , GETH (Salamanca, Spain)
 
17:45-19:00
MICRORNA SIGNATURE OF CD34 CELLS IN MYELODYSPLASTIC SYNDROME PATIENTS WITH DEL(5Q) 0253
Bruchova, Hana, Merkerova, Michaela, Vasikova, Alzbeta, Belickova, Monika, Cermak, Jaroslav (Prague, Czech Republic)
 
17:45-19:00
THE CAPACITY OF THE HYPOMETHYLATING AGENTS AZACYTIDINE AND DECITABINE TO INDUCE APOPTOSIS AND CELL CYCLE ARREST DEPENDS ON THE ACTIVATION OF THE DNA-DAMAGE RESPONSE PATHWAY 0254
Boehrer, Simone, Adès, Lionel, Gardin, Claude, Fenaux, Pierre, Kroemer, Guido (Bobigny, France)
 
17:45-19:00
TREATMENT OUTCOME ACCORDING TO PRETREATMENT RISK GROUP IN MDS PATIENTS WHO WERE TREATED WITH AZACITIDINE 0255
Sohn, Sang Kyun, Baek, Jin Ho, Moon, Joon Ho, Park, Jae Hoo, Chung, Joo Seop , Won, Jong Ho, Lee, Sang Min , Joo, Young Don, Kim, Yeo Kyeoung, Kim, Hyeong Joon , Jo, Deog Yeon , Kim, Jong Gwang , Chae, Yee Soo (Daegu, South-Korea)
 
17:45-19:00
RUNX1 MUTATIONS IN DE NOVO MDS AND CMML AT BOTH DIAGNOSIS AND AML TRANSFORMATION: A COMPARATIVE ANALYSIS ON 80 MATCHED PAIRED MARROW SAMPLES 0256
Kuo, Ming-Chung, Liang, Der-Cherng, Huang, Chein-Fuang, Shih, Yu-Shu, Lin, Tung-Liang, Wu, Jin-Hou, Shih, Lee-Yung (Taipei, Taiwan)
 
17:45-19:00
EXPRESSION OF P53 OR CYTOPLASMIC NUCLEOPHOSMINE ASSOCIATED WITH INCREASED RISK OF DISEASE PROGRESSION IN MYELODYSPLASTIC SYNDROME WITH ISOLATED DEL(5Q) 0257
Martin, Jädersten, Saft, Leonie, Garelius, Hege, Hast, Robert, Nilsson, Lars, Samuelsson, Jan, Porwit, Anna, Hellström-Lindberg, Eva (Stockholm, Sweden)
 
17:45-19:00
DIFFERENT PATTERNS OF TELOMERASE REVERSE TRANSCRIPTASE (HTERT) MRNA VARIANT EXPRESSION PROFILES IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES 0258
Verrou, Evgenia, Kaloutsi, Vassiliki, Katodritou, Eirini, Gastari, Vassiliki, Banti, Anastasia, Nikitidou, Anna, Garypidou, Vasilia, Zervas, Konstantinos, Kotoula, Vassiliki (Thessaloniki, Greece)
 
17:45-19:00
INCREASED FREQUENCY OF REGULATORY T-CELLS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES 0259
Fozza, Claudio, Longu, Francesco, Contini, Salvatore, Galleu, Antonio, Virdis, Patrizia, Simula, Maria Pina, Longinotti, Maurizio (Sassari, Italy)
 
17:45-19:00
PHOSPHOINOSITIDE-PHOSPHOLIPASE C (PI-PLC) BETA1 AS A TARGET OF EPIGENETIC THERAPY IN MDS PATIENTS 0260
Follo, Matilde, Finelli, Carlo, Mongiorgi, Sara, Clissa, Cristina, Chiarini, Francesca, Bosi, Costanza, Baccarani, Michele, Manzoli, Lucia, Martinelli, Giovanni, Martelli, Alberto, Cocco, Lucio (Bologna, Italy)
 
17:45-19:00
HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROME – SYSTEMATIC REVIEW AND META-ANALYSIS 0261
Gurion, Ronit, Vidal, Liat, Gafter-Gvili, Anat, Belnik, Yulia, Yeshurun, Moshe, Raanani, Pia, Shpilberg, Ofer (Petach Tikva, Israel)
 
17:45-19:00
CYTOGENETIC EVOLUTION (CE) IN MDS: IS IT PREDICTIVE OF OVERALL SURVIVAL (OS) AND RISK OF MDS/AML EVOLUTION? 0262
Bernasconi , Paolo, Klersy, Catherine, Boni, Marina, Dambruoso, Irene, Cavigliano, Paola Maria, Zappatore, Rita, Giardini, Ilaria, Calatroni, Silvia, Rocca, Barbara, Calvello, Celeste, Caresana, Marilena, Lazzarino, Mario (Pavia, Italy)
 
17:45-19:00
ARHGAP21, A PARTNER OF ALPHA-CATENIN, MAY BE ALTERED EXPRESSED IN BONE MARROW CELLS FROM PATIENTS WITH MYELODYSPLATIC SYNDROMES LACKING 5Q DELETION 0263
Barcellos, Karin, Winnischofer , Sheila, Lazarini , Mariana, Duarte , Adriana, Traina , Fabiola, Costa , Fernando, Saad , Sara (Campinas, Brazil)
 
17:45-19:00
THALIDOMIDE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES: A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE PUBLISHED STUDIES 0264
Musto, Pellegrino, D'Auria, F., Grieco, V., Sparano, A., Zonno, A., Guariglia, R., Pietrantuono, G., Villani, O., Martorelli, M.C., Mansueto, G., Lerose, R., Marchetti, M. (Rionero In Vulture, Italy)
 
17:45-19:00
MESENCHYMAL STEM CELLS FROM 5Q- SYNDROME PATIENTS SHOW INCREASED EXPRESSION OF FGF4 AND IL32 IN COMPARISON TO OTHER MDS 0265
Santamaria, Carlos, Lopez-Villar, Olga, Sanchez-Guijo, Fermin, Hernandez-Campo, Pilar, Del Cañizo, Consuelo (Salamanca, Spain)
 
17:45-19:00
"MONOCYTOSIS" THAT DEFINES CHRONIC MYELOMONOCYTIC LEUKEMIA INCLUDES A PROPORTION OF IMMATURE GRANULOCYTES WITH A DISTINCT MOLECULAR SIGNATURE 0266
Jacquel, Arnaud, Droin, Nathalie , Ciudad, Marion , Racoeur, Cindy , Gelsi-Boyer, Véronique , Calier, Patrick , Girodon, François , Guery, Leslie , Quesnel, Bruno , Fenaux, Pierre , Lafon, Ingrid , Beyne-Rauzy, Odile , Stamatoulas, Aspasia , Dreyfus, François , Boyer, Françoise , Bonnotte, Bernard , Raynaud, Sophie , Cavé, Hélène , Guercy-Bresler, Agnès , Besson, Caroline , Truntzer, Caroline , Mugneret, Francine , Birnbaum, Daniel , Fontenay, Michaëla , Solary , Eric (Dijon, France)
 
17:45-19:00
ISOLATED DEL 20Q DEFINES A SUBGROUP OF MDS PATIENTS WITH LOWER BLAST COUNTS AND MORE FREQUENT THROMBOCYTOPENIA 0267
Braun, Thorsten, De Botton, Stéphan, Guenda, Khaled, Leroux, Geneviève, Taksin, Anne-Laure, Park, Sophie, Beyne-Rauzy, Odile, Chevret, Sylvie, Fontenay, Michaéla, Cassinat, Bruno, Lazareth, Anne, Terré, Christine, Vey, Norbert, Guerci, Agnès, Dreyfus, François, Bordessoule, Dominique, Stamatoullas, Aspasia, Castaigne, Sylvie, Eclache, Virginie, Fenaux, Pierre, Adès, Lionel (Bobigny, France)